

a16z Podcast
Andreessen Horowitz
The a16z Podcast discusses tech and culture trends, news, and the future – especially as ‘software eats the world’. It features industry experts, business leaders, and other interesting thinkers and voices from around the world. This podcast is produced by Andreessen Horowitz (aka “a16z”), a Silicon Valley-based venture capital firm. Multiple episodes are released every week; visit a16z.com for more details and to sign up for our newsletters and other content as well!
Episodes
Mentioned books

Jul 7, 2020 • 6min
Why We Shouldn’t Fear AI in Healthcare
Vijay Pande, author and thought leader on AI in healthcare, addresses the common fears surrounding AI's 'black box' issue. He highlights how misconceptions can overshadow the benefits of AI technologies, showcasing their potential to improve transparency and patient outcomes. Vijay contrasts human intuition with AI's data-driven decision-making, advocating for a collaborative future where AI enhances understanding and reshapes human roles in healthcare. It's a compelling argument for embracing rather than fearing innovation.

Jul 7, 2020 • 20min
When One App Rules Them All: The Case of WeChat and Mobile in China
Connie Chan, author and analyst, dives into WeChat's incredible journey from a messaging app to an all-encompassing super app. She discusses how WeChat integrates social interactions, commerce, and innovative features, reshaping user experiences. Connie also explores its impact on mobile messaging and enterprise solutions, highlighting the effective use of official accounts for engagement and contrasting WeChat's mobile-first approach with earlier platforms like QQ. Her insights shed light on the future of mobile applications both in China and globally.

Jul 7, 2020 • 15min
Every Company Is a Fintech Company
Angela Strange, a venture capitalist at Andreessen Horowitz and fintech expert, discusses transformative shifts in the financial sector. She highlights the stark differences between affluent banking systems and those leaving many underserved. Strange emphasizes the pivotal role of technology in making financial services more accessible and affordable, particularly for those traditionally neglected. She also delves into the challenges faced by fintech startups amid regulatory pressures but remains optimistic about innovation paving the way for a more equitable financial landscape.

Jul 7, 2020 • 51sec
Read-Alouds, Continued
Discover the captivating evolution of audio content in the podcast landscape. Engage with classic read-alouds that spark curiosity and conversation. Delve into why every company is set to transform into a fintech powerhouse, unravel the dominance of WeChat in China, and explore the implications of AI’s ‘black box’ in healthcare. It’s a thought-provoking journey through finance, technology, and the future of communication.

Jul 5, 2020 • 10min
Journal Club: Revisiting Eroom's Law
Explore the fascinating concept of Eroom’s Law, which highlights the rising costs of drug development compared to Moore’s Law. Discover how advancements in AI and data analysis are revolutionizing the industry, making drug creation more efficient. The discussion dives into the evolution of drug approval processes, emphasizing personalized therapies and agile trial methods. Listen as experts analyze recent trends, debating whether the tide is turning against Eroom’s Law and what this means for the future of biopharma.

Jun 30, 2020 • 35min
Preventing Pandemics with Genomic Epidemiology
Trevor Bedford, an Associate Professor at the Fred Hutchinson Cancer Research Center and co-creator of Nextstrain, discusses the pivotal role of genomic epidemiology in public health. He highlights how viral mutations and animal-to-human spillover can be managed to prevent future pandemics. Trevor delves into the transformation brought by COVID-19 on scientific communication, emphasizing the importance of preprints and open science. He also explores advancements in sequencing technology and its potential to enhance pathogen detection and disease monitoring.

Jun 28, 2020 • 17min
Journal Club: Therapeutic Video Game on Trial
Join Justin Larkin, a partner at Andreessen Horowitz’s bio fund and former entrepreneur, as he dives into the revolutionary world of therapeutic video games. Discover how the FDA approved EndeavorRx, the first prescription video game for children with ADHD. Larkin discusses impressive trial results, comparing this innovative approach to traditional medication. He also explores its adaptability, safety concerns, and the potential for personalized treatment, sparking a conversation on the future of digital therapeutics in pediatric mental health.

Jun 27, 2020 • 36min
Gross Margins, Early to Late: What They Do (and Don't) Tell You
Explore the pivotal role of gross margins as key financial metrics for startups. Delve into the advantages of subscription revenue models and the transition from one-time sales. Understand the unique challenges faced by software companies, especially in managing costs and profitability. Discover how evolving business models, like SaaS, impact operational efficiency and margins. Gain insights on navigating the complexities of margins during a startup's growth journey, emphasizing strategic financial awareness and sustainable profitability.

8 snips
Jun 24, 2020 • 23min
Building Products for Power Users
Rahul Vohra, the founder of Superhuman, dives into the artistry behind creating exceptional user experiences for power users. He discusses the expectations of digital natives who desire software that’s not only functional but pleasurable. Vohra explores innovative user interface design and the importance of onboarding in transforming regular users into prosumers. He emphasizes integrating game design principles with SaaS products and shares insights on effective pricing strategies that elevate a product's appeal to the right audience.

Jun 21, 2020 • 21min
Journal Club: Building a Better Chloroplast
Judy Savitskaya, a partner at Andreessen Horowitz specializing in synthetic biology, joins to discuss groundbreaking research that seeks to revolutionize photosynthesis. The conversation dives into a synthetic chloroplast combining natural and artificial elements to enhance carbon fixation and improve crop efficiency. Savitskaya explores the inefficiencies of the Rubisco enzyme and innovative strategies for overcoming its limitations. The use of microfluidics in experimentation adds a fascinating layer to their discussion on the future of agricultural biotechnology.